Ginkgo Bioworks Holdings (DNA) Assets (2020 - 2026)

Ginkgo Bioworks Holdings' Assets history runs 7 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• Quarterly Assets fell 20.13% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (down 20.13% YoY) and the FY2025 annual result came in at $1.1 billion, down 18.71% from the prior year.
• Assets was $1.0 billion for Q1 2026 at Ginkgo Bioworks Holdings, down from $1.1 billion in the prior quarter.
• Across five years, Assets topped out at $2.5 billion in Q4 2022 and bottomed at $1.0 billion in Q1 2026.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets climbed 22.61% — and 2024, when it slumped 34.56%.
• Ginkgo Bioworks Holdings' Assets stood at $2.5 billion in 2022, then tumbled by 34.42% to $1.7 billion in 2023, then retreated by 17.29% to $1.4 billion in 2024, then dropped by 18.71% to $1.1 billion in 2025, then decreased by 7.74% to $1.0 billion in 2026.
• Business Quant data shows DNA's Assets at $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.2 billion in Q3 2025.